Literature DB >> 30299432

Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome.

Agathe Dumont1, Geoffroy Robin, Didier Dewailly.   

Abstract

PURPOSE OF REVIEW: Polycystic ovarian syndrome (PCOS) is the most common cause of chronic anovulation and hyperandrogenism in young women and represents a true public health concern and an economic burden. RECENT
FINDINGS: The pathophysiology of PCOS is still not fully understood, but progresses have been made and the relationships between anti mullerian hormone (AMH), follicle stimulating hormone, luteinizing hormone, E2 and androgens have been explored. The follicle excess plays a central role in the syndrome and AMH is definitively a major component of this phenomena.
SUMMARY: The aim of this chapter is to present the recent work studying the role of AMH in the pathophysiology of PCOS and to discuss the improvement that serum AMH assay brings in the diagnosis of PCOS.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30299432     DOI: 10.1097/MED.0000000000000445

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  9 in total

1.  Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome.

Authors:  Youran Li; Yanhong Zhai; Lin Li; Yifan Lu; Shaofei Su; Ying Liu; Zhengwen Xu; Mingwei Xin; Qiaoli Zhang; Zheng Cao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 2.  Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.

Authors:  Jagoda Kruszewska; Hanna Laudy-Wiaderny; Michał Kunicki
Journal:  Int J Environ Res Public Health       Date:  2022-02-13       Impact factor: 3.390

3.  Comparative effectiveness of aerobic exercise versus Yi Jin Jing on ovarian function in young overweight/obese women with polycystic ovary syndrome: study protocol for a randomized controlled trial.

Authors:  Jing Zhao; Antonnette Ketlhoafetse; Xiangyun Liu; Yang Cao
Journal:  Trials       Date:  2022-06-03       Impact factor: 2.728

Review 4.  Polycystic Ovary Syndrome: Ontogeny in Adolescence.

Authors:  Christine M Burt Solorzano; Christopher R McCartney
Journal:  Endocrinol Metab Clin North Am       Date:  2021-01-11       Impact factor: 4.741

Review 5.  Perturbations in Lineage Specification of Granulosa and Theca Cells May Alter Corpus Luteum Formation and Function.

Authors:  Mohamed A Abedel-Majed; Sarah M Romereim; John S Davis; Andrea S Cupp
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-29       Impact factor: 6.055

6.  The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups.

Authors:  Yu Ran; Qiang Yi; Cong Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-25       Impact factor: 3.168

7.  Abnormal Elevation of Anti-Mullerian Hormone and Androgen Levels Presenting as Granulosa Cell Tumor.

Authors:  Hongbin Chi; Ning Huang; Huamao Liang; Rong Li; Congrong Liu; Jie Qiao
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

Review 8.  Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS.

Authors:  Ewa Rudnicka; Michał Kunicki; Anna Calik-Ksepka; Katarzyna Suchta; Anna Duszewska; Katarzyna Smolarczyk; Roman Smolarczyk
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

Review 9.  Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.

Authors:  Didier Dewailly; Anne-Laure Barbotin; Agathe Dumont; Sophie Catteau-Jonard; Geoffroy Robin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-09       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.